Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$103.00
+4.4%		$80.30
$61.22
▼
$104.78
$11.20B0.852.34 million shs2.19 million shs
Mexco Energy Co. stock logo
MXC
Mexco Energy
$9.01
-3.2%		$8.54
$7.16
▼
$16.48
$18.43M0.3322,574 shs68,447 shs
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
$15.27
-0.5%		$14.70
$12.01
▼
$15.65
N/AN/A21,021 shs36,814 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
0.00%-4.33%+26.80%+46.29%+46.66%
Mexco Energy Co. stock logo
MXC
Mexco Energy
0.00%-1.56%+4.05%-1.23%+10.19%
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
0.00%-1.44%+5.07%+8.63%+23.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$103.00
+4.4%		$80.30
$61.22
▼
$104.78
$11.20B0.852.34 million shs2.19 million shs
Mexco Energy Co. stock logo
MXC
Mexco Energy
$9.01
-3.2%		$8.54
$7.16
▼
$16.48
$18.43M0.3322,574 shs68,447 shs
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
$15.27
-0.5%		$14.70
$12.01
▼
$15.65
N/AN/A21,021 shs36,814 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
0.00%-4.33%+26.80%+46.29%+46.66%
Mexco Energy Co. stock logo
MXC
Mexco Energy
0.00%-1.56%+4.05%-1.23%+10.19%
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
0.00%-1.44%+5.07%+8.63%+23.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
2.62
Moderate Buy$91.20-11.46% Downside
Mexco Energy Co. stock logo
MXC
Mexco Energy
0.00
N/AN/AN/A
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest N4P, HALO, MXC, and RGT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B) ➝ Buy (B-)
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$96.00 ➝ $105.00
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Outperform$92.00 ➝ $93.00
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$75.00 ➝ $95.00
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Leerink Partners logo
Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$83.00 ➝ $110.00
8/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$95.00 ➝ $115.00
7/31/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeBuy (B-) ➝ Buy (B)
7/21/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/21/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$95.00
(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$1.40B8.37$4.98 per share20.68$0.42 per share245.24
Mexco Energy Co. stock logo
MXC
Mexco Energy
$6.79M2.72$1.24 per share7.25$8.81 per share1.02
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
$88.69MN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$316.89M$3.3530.7511.120.4024.86%260.98%23.91%11/2/2026 (Estimated)
Mexco Energy Co. stock logo
MXC
Mexco Energy
$1.35M$0.7514.30N/AN/A18.73%7.57%6.94%N/A
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest N4P, HALO, MXC, and RGT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$1.79$2.28+$0.49$1.90$402.28 million$481.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
N/AN/AN/AN/AN/A
Mexco Energy Co. stock logo
MXC
Mexco Energy
$0.101.11%N/A13.33%N/A
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
$0.191.24%N/AN/AN/A

Latest N4P, HALO, MXC, and RGT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/4/2026
Mexco Energy Co. stock logo
MXC
Mexco Energy
annual$0.101.27%6/15/20266/15/20266/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
13.50
2.71
2.31
Mexco Energy Co. stock logo
MXC
Mexco Energy
N/A
3.53
3.53
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
97.79%
Mexco Energy Co. stock logo
MXC
Mexco Energy
5.89%
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
N/A

Insider Ownership

CompanyInsider Ownership
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
2.50%
Mexco Energy Co. stock logo
MXC
Mexco Energy
55.53%
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
390113.50 million110.66 millionOptionable
Mexco Energy Co. stock logo
MXC
Mexco Energy
52.05 million961,000Not Optionable
Royce Global Value Trust, Inc. stock logo
RGT
Royce Global Value Trust
N/AN/AN/ANot Optionable

Recent News About These Companies

Royce Global Trust (NYSE: RGT) as of Jun 30, 2026
July 23, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-jun-30-2026-302833682.html
Royce Global Trust (NYSE: RGT) as of May 31, 2026
June 24, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-may-31-2026-302809650.html
Royce Global Trust (NYSE: RGT) as of Apr 30, 2026
May 20, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-apr-30-2026-302778103.html
Royce Global Trust (NYSE: RGT) as of Mar 31, 2026
May 4, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-mar-31-2026-302761394.html
Royce Global Trust (NYSE: RGT) as of Feb 28, 2026
March 25, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-feb-28-2026-302725448.html
Royce Global Trust Manager FY 2025 Commentary
March 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4883074-royce-global-trust-manager-fy-2025-commentary
Royce Global Trust (NYSE: RGT) as of Jan 31, 2026
February 27, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-jan-31-2026-302699874.html
Royce Global Value Trust: Royce Global Trust (NYSE: RGT) as of Dec 31, 2025
January 27, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-01/67532867-royce-global-value-trust-royce-global-trust-nyse-rgt-as-of-dec-31-2025-008.htm
Royce Global Trust reports NAV of $15.24 as of December 31, 2025
January 27, 2026  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/royce-global-trust-reports-nav-of-1524-as-of-december-31-2025/ar-AA1V5fpt
Royce Global Trust (NYSE: RGT) as of Dec 31, 2025
January 26, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-dec-31-2025-302670384.html
Royce Global Trust (NYSE: RGT) as of Nov 30, 2025
December 23, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-nov-30-2025-302648868.html
Royce Global Trust, Inc. (NYSE-RGT) declares Year-end Common Stock Distribution of $0.19 Per Share
December 1, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-inc-nyse-rgt-declares-year-end-common-stock-distribution-of-0-19-per-share-302629426.html
Royce Global Trust (NYSE: RGT) as of Oct 31, 2025
November 24, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-oct-31-2025-302624888.html
Charles Royce Sells 2,533 Shares of Royce Global Value Trust (NYSE:RGT) Stock
November 8, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-rgt-insider-buying-and-selling-2025-11-08/
Royce Global Value Trust (NYSE:RGT) Insider Charles Royce Sells 8,432 Shares
November 7, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-rgt-insider-buying-and-selling-2025-11-07/
Royce Global Trust (NYSE: RGT) as of Sep 30, 2025
October 27, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-sep-30-2025-302595632.html
Royce Global Trust (NYSE: RGT) as of Jul 31, 2025
September 2, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/royce-global-trust-nyse-rgt-as-of-jul-31-2025-302544187.html
Christopher Clark Acquires 1,600 Shares of Royce Global Value Trust (NYSE:RGT) Stock
August 28, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-rgt-insider-buying-and-selling-2025-08-28/
Royce Global Value Trust: Royce Global Trust (NYSE: RGT) as of Jun 30, 2025
August 3, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/66049224-royce-global-value-trust-royce-global-trust-nyse-rgt-as-of-jun-30-2025-008.htm
RGT: Deep Discount On Global Small-Caps But Unappealing Distribution Policy
July 6, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4799495-rgt-deep-discount-on-global-small-caps-but-unappealing-distribution-policy

New MarketBeat Followers Over Time

Media Sentiment Over Time

Halozyme Therapeutics stock logo

Halozyme Therapeutics NASDAQ:HALO

$103.00 +4.34 (+4.40%)
As of 04:00 PM Eastern

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.

Mexco Energy stock logo

Mexco Energy NYSE:MXC

$9.01 -0.30 (-3.22%)
As of 04:00 PM Eastern

Mexco Energy Corporation, an independent oil and gas company, engages in the acquisition, exploration, development, and production of natural gas, crude oil, condensate, and natural gas liquids in the United States. It owns partial interests in approximately 6,400 gross producing wells located in the states of Texas, New Mexico, Oklahoma, Louisiana, Alabama, Mississippi, Arkansas, Wyoming, Kansas, Colorado, Montana, Virginia, North Dakota, and Ohio. It also owned leasehold mineral, royalty, and other interests in approximately 2,768 net acres. The company was formerly known as Miller Oil Company and changed its name to Mexco Energy Corporation in April 1980. Mexco Energy Corporation was incorporated in 1972 and is based in Midland, Texas.

Royce Global Value Trust stock logo

Royce Global Value Trust NYSE:RGT

$15.27 -0.08 (-0.52%)
As of 03:59 PM Eastern

Royce Global Value Trust, Inc. was a closed ended equity mutual fund launched and managed by Royce & Associates, LLC. It invests in the public equity markets across the globe. The fund spreads its investments across diversified sectors. It invests in value oriented stocks of small-cap and micro-cap companies. The fund benchmarks the performance of its portfolio against the Russell Global SC Index. Royce Global Value Trust, Inc. was formed on November 26, 1986 and is domiciled in the United States.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas